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All retroviral genomic RNAs contain a cis-acting packaging signal
by which dimeric genomes are selectively packaged into nascent
virions. However, it is not understood how Gag (the viral structural
protein) interacts with these signals to package the genome with
high selectivity. We probed the structure of murine leukemia virus
RNA inside virus particles using SHAPE, a high-throughput RNA
structure analysis technology. These experiments showed that
NC (the nucleic acid binding domain derived fromGag) bindswithin
the virus to the sequence UCUG-UR-UCUG. Recombinant Gag and
NC proteins bound to this same RNA sequence in dimeric RNA in
vitro; in all cases, interactions were strongest with the first U
and final G in each UCUG element. The RNA structural context is
critical: High-affinity binding requires base-paired regions flanking
this motif, and two UCUG-UR-UCUGmotifs are specifically exposed
in the viral RNA dimer. Mutating the guanosine residues in these
two motifs—only four nucleotides per genomic RNA—reduced
packaging 100-fold, comparable to the level of nonspecific packa-
ging. These results thus explain the selective packaging of dimeric
RNA. This paradigm has implications for RNA recognition in gener-
al, illustrating how local context and RNA structure can create
information-rich recognition signals from simple single-stranded
sequence elements in large RNAs.
retrovirus ∣ RNA recognition code ∣ RNA SHAPE chemistry
Expression of a single viral protein, termed Gag, is sufficient forassembly of retrovirus-like particles in mammalian cells. If
present in the cell, the viral genomic RNA (vRNA) is selectively
packaged into nascent particles; this selectivity is due to a cis-
acting packaging signal in the RNA, termedΨ (1, 2). Remarkably,
when no Ψ-containing RNA is present, Gag still assembles effi-
ciently, encapsidating cellular mRNAs nonselectively in place of
the vRNA (3–5).
There are many indications that Ψ represents a high-affinity
binding site for the Gag protein both in HIV-1 and in simpler ret-
roviruses (6–14). However, the molecular mechanisms underlying
selective encapsidation of vRNAs are incompletely understood,
as are the features that enable Gag to bind preferentially to
vRNA rather than to other cellular RNAs. Gag proteins contain
several distinct domains, always including matrix (MA), capsid,
and nucleocapsid (NC). vRNA packaging is mediated by the
multidomain Gag protein, but Gag is cleaved following release
of the virus from the cell. The NC domain plays a principal role
in interactions with nucleic acids and is largely responsible for
the specific interaction between Gag and its cognate viral RNA
(12, 13). This domain of Gag is highly basic and contains one
or more “zinc knuckles” with a conserved spacing of Zn2þ-coor-
dinating cysteine and histidine residues. Mutations that abolish
Zn2þ coordination impair selective encapsidation of vRNAduring
virus assembly (6, 15). In addition,MAdomains ofmany retroviral
Gag proteins interact with nucleic acids (16–21) and may also
contribute to specific interactions between Gag and vRNA.
When the vRNA is extracted from virus particles, it is found to
be a dimer, in which two molecules of the same (positive-strand)
polarity are joined together by a limited number of base pairs.
There is strong, albeit indirect, evidence that dimerization is
linked to packaging (15, 22–25), so that only dimers of vRNA
are selectively packaged. The selective packaging of dimers,
but not monomers, of MuLV vRNA likely reflects, in part, the
exposure of UCUG sequence elements that become specifically
accessible in dimers (26). However, MuLV nucleocapsid binds to
nearly any sequence of the form NNNG (26–28), and it is not
clear how recognition of this simple RNA element with only a
single conserved nucleotide might direct selective packaging.
Moreover, the minimal sequence required to mediate packaging
(23, 29), dimerization (30, 31), and interaction with Gag (32)
spans ∼170 nucleotides. It has proven to be very difficult to dis-
sociate the contributions of direct protein-RNA interactions from
interactions that are required to maintain RNA base pairing and
tertiary interactions in this region.
In the present work, we outline a broadly useful approach for
determining the protein recognition code for interactions invol-
ving simple sequence elements embedded in a large RNA struc-
ture. We show that NC binds to two specific UCUG-UR-UCUG
motifs within mature MuLV particles; that recombinant MuLV
Gag, as well as NC, binds specifically to these motifs in vitro;
that Gag binding is notably more selective than NC binding; that
highest affinity binding requires that these sequences be pre-
sented in a precise structural context; and that these motifs are
crucial elements in the vRNA packaging signal.
Results
We previously used SHAPE (selective 2′-hydroxyl acylation ana-
lyzed by primer extension) to develop a model for the secondary
structure of the MuLV dimerization domain, using authentic,
dimeric genomic RNA gently extracted from virions (termed the
ex virio RNA) (Fig. 1A) (33). SHAPE uses a chemical reaction at
the RNA 2′-hydroxyl position to measure local nucleotide flex-
ibility (34, 35); flexibility can be reduced either by base pairing or
by bound protein. We found that the two RNA strands in the
dimer are held together by intermolecular base pairs in two
palindromic stretches, termed PAL1 and PAL2, and by G-C
base-pairing interactions in a highly conserved double stem-loop
motif (SL1-SL2) (31, 33, 36–38). These elements are separated
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by two distinct flexible elements, between PAL1 and SL0 and
between PAL2 and SL1, respectively (Fig. 1A).
We have now extended these experiments by performing
SHAPE on vRNA inside intact virions (termed the in virio state),
similar to previous experiments performed on HIV-1 virion RNA
(39, 40). We also evaluated vRNA structure within viral particles
after exposure of the virions to 2,2′-dithiodipyridine (Aldrithiol-
2, AT-2) (39, 41). This compound, a mild oxidizing agent, pene-
trates the virus particle and compromises NC zinc knuckle struc-
ture by disrupting native cysteine-Zn2þ interactions (we term this
the AT-2-treated state). NC is thought to bind tightly to RNA
within the virion, due in part to this zinc knuckle motif (6–8,
26, 41, 42). Thus, AT-2 treatment disrupts or weakens NC-
RNA interactions by oxidation of cysteine residues in NC but
has no detectable effect on the exterior of HIV-1 particles (43).
Structural Analysis of Authentic MuLV Genomic RNA Dimers. Our
analysis of the genomic RNA in virio yielded SHAPE reactivities
for >95% of all positions in the dimerization domain (red histo-
grams, Fig. 2A). As expected, each of the elements that stabilize
the dimer state—PAL1, PAL2, and SL1-SL2—have low SHAPE
reactivities. We then performed analogous experiments using vir-
ions that had been pretreated with AT-2, or using deproteinized
RNA purified from virions (the AT-2 treated and ex virio states,
respectively, Fig. 2A). The PAL1 and PAL2 intermolecular du-
plexes and the SL1-SL2 domain were unreactive in each of these
states, indicating that their lack of reactivity is due to stable
RNA–RNA interactions, and not protein–RNA interactions or
other features of the intravirion environment.
In strong contrast, clear changes in nucleotide reactivity in the
AT-2 treated and ex virio states, relative to the in virio state, occur
throughout the regions that link the PAL1, PAL2, and SL1-SL2
structural elements. These differences are readily detected in
SHAPE reactivity difference plots (Fig. 2B). AT-2 treatment
(Fig. 2B, dark blue) rendered some regions more flexible (nts
220–235, immediately 3′ of PAL1; nts 299–309, just 3′ of PAL2;
and nts 338–341, the GGAA bulge in SL1) and others less flexible
(nts 246–259 and 272–279). The AT-2 treated profile was similar
to that of deproteinized, ex virio, viral RNA (compare histograms
in Fig. 2B). Thus, AT-2 treatment evidently disrupts most pro-
tein–vRNA interactions within the virus particle in this region
of the genome. Sites of strongest protein–RNA interactions
inside the virion correspond to regions of negative SHAPE reac-
tivity differences: These are emphasized with bars in Fig. 2B.
Identification of High-Affinity Binding Sites for MuLV Gag and NC.
Using purified components, we tested the possibility that the sites
protected within the virion (Fig. 2) represent high-affinity binding
sites for viral proteins. We prepared a 331-nt-long RNA, contain-
ing the ∼170-nt minimal dimerization active sequence (MiDAS)
domain (30, 38) that forms homogenous monomers and dimers
and recapitulates the structure of the ex virio dimer [except that
one structure, SL0, forms only in the context of the full-length
genomic RNA (33)]. Dimers of this transcript were incubated
with recombinant MuLV Gag or NC protein; the resulting ribo-
nucleoprotein complexes were then analyzed by SHAPE for
comparison with the naked dimeric transcript.
We initially evaluated binding by Gag and NC to the MiDAS
RNA dimer under near-physiological ionic conditions (200 mM
potassium acetate, 5 mM MgCl2), but observed no NC-specific
effects and only weak effects of Gag binding. However, at lower
ionic strength (40 mM potassium acetate or NaCl, 0.8 mM
MgCl2), we observed clear structural changes upon addition of
Gag and NC. We therefore first formed the dimer under the
near-physiological ion condition and then diluted the RNAs to
the lower ionic strength prior to protein addition. The dimer
structure is retained upon dilution (see Methods). Gag-RNA
interactions were readily detected at a ratio of only 5 Gag mole-
cules per MuLV RNA, whereas detection of any effect of NC
required addition of 250 NC molecules per each 331-nt RNA
strand. Addition of Gag or NC to the MiDAS RNA induced large
changes in SHAPE reactivities, and difference plots revealed that
these changes occurred predominantly in the regions between
PAL1 and PAL2 and between PAL2 and SL1 (Fig. S1).
Together with the data in Fig. 2, the SHAPE data enabled us to
make four instructive comparisons: in virio versus (protein-free)
ex virio; in virio versus AT-2 treated; and, for the dimer of the
331-nt transcript, the effects of Gag and NC binding. The first
two comparisons reflect NC-dependent protections inside intact
virions, whereas the latter two report the binding of Gag and NC
to transcripts in vitro. We quantified each of these SHAPE-
derived comparisons by calculation of a protection factor.
Remarkably, the protection patterns for all four comparisons
are highly similar (Fig. 3). For every comparison, there are strong
sites of protection immediately 3′ of PAL1 (nts 220–235) and
PAL2 (nts 299–309). Both sites contain two copies of the
UCUG sequence previously shown to interact with NC in short
A
B
Fig. 1. Structure of the MuLV dimerization domain in the dimer state.
(A) Secondary structure. The two RNA strands are shown in black and gray.
Major structural elements are labeled. Protein-binding sites at UCUG tandem
sequences identified in this work are boxed. (B) Local structure at each
recognition site based on binding experiments (Fig. 5) and on prior work
showing extensive helix packing and tertiary structure in this region of
the MuLV RNA (38, 45).








RNAs (26, 28). Nucleotides within the tandem UCUG motifs
exhibit a conserved pattern, such that the first U and the final
G show the strongest protection from SHAPE in the presence
of viral proteins (emphasized with red lines, Fig. 3).
Although the overall patterns of protection are similar for the
four comparisons, there are notable differences at selected posi-
tions. First, in addition to conserved protections at the tandem
UCUG sequences, positions 220–223 also show protection, but
predominantly in the comparison between the in virio and ex virio
states and for the experiments employing purified NC (Fig. 3 A
and D). This site apparently reflects binding by NC via a mechan-
ism that does not depend upon the zinc knuckle motif because
it is not affected by AT-2 treatment (compare panels, Fig. 3 A
and B). Second, at the PAL2 tandem binding site (nts 299–309),
the protection pattern induced by recombinant NC (Fig. 3D) has
a different local pattern than observed for any of the other three
comparisons: The first U in the UCUG sequence shows little
or no protection with NC, whereas this nucleotide is strongly
protected in the other three comparisons.
Specific Gag Binding to the Dimerization Domain. We next analyzed
the binding affinity of Gag to the full-length, dimeric MiDAS
RNA. We evaluated Gag binding affinities by nitrocellulose filter
partitioning, using excess tRNA to suppress the nonspecific bind-
ing activity of Gag. There is a bimodal pattern of binding by
Gag to the wild-type RNA (Fig. 4). Fitting this profile to a model
postulating two consecutive, unlinked binding events gave a high-
affinity mode with an apparent dissociation constant (Kapp;1)
of ∼6 nM, and a second mode with Kapp;2 ∼ 500 nM (circles and
solid lines, Fig. 4).
The SHAPE protection data (Fig. 3) suggest that the core
recognition element for Gag and NC has the consensus
UCUG-UR-UCUG. To test the role of the tandemUCUGmotifs
in the binding of Gag to these dimeric transcripts, we mutated
both G4 residues in the 5′ repeat (mutant M1), in the 3′ repeat
(M2), or in both repeats (M1M2) (see Fig. 1A). The higher-affi-
nity binding mode is only ∼2-fold weaker in M1 and M2 (triangle
symbols, Fig. 4), but ∼6-fold weaker for M1M2 RNA than for the
wild-type control (squares, Fig. 4). Binding in the second, weaker
phase is similar for all of the RNAs. As a further test of the spe-
cificity of Gag binding to the MiDAS dimer, we also monitored
the binding of ðlysineÞ25 to the wild-type and mutant RNAs. We
found (diamonds, Fig. 4) that this basic peptide binds poorly to all
four RNAs, with Kapp > 1 μM. This polycation thus appears to
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Fig. 2. Structural differences in the Ψ domain as a
function of genomic RNA state. (A) SHAPE reactivity
histograms for the intact in virio (red), AT-2 treated
(dark blue), and ex virio (light blue) vRNA. Broken
lines indicate a small number of nucleotides that were
not analyzed due to high background. (B) Difference
plot calculated by subtracting the ex virio (light blue
columns) or AT-2 treated (dark blue columns) experi-
ments from the in virio data. Positive and negative
amplitudes indicate nucleotides that show greater
or lesser flexibility, respectively, in virio as compared
to the other two states. The two strongest sites of in-
creased reactivity in the AT-2 treated and ex virio
states are emphasized with bold lines.























































Fig. 3. Identification of specific protein
binding sites in the MuLV Ψ region. Protec-
tion factors correspond to (I− − IþÞ∕Iþ,
where Iþ and I− are SHAPE reactivities in
the presence and absence of protein, respec-
tively. Conserved reactivity patterns at UCUG
sequences are outlined in red. Nucleotides
that were unreactive both before and after
protein addition (reactivity less than 0.15
SHAPE units) are omitted.
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mimic the low-affinity but not the high-affinity mode of Gag
binding; its binding is independent of the UCUG motif.
Defining a Minimal Gag Binding Site. We next evaluated Gag-RNA
interactions in the context of simplified RNAs that limit oppor-
tunities for nonspecific interactions. Both instances of the
UCUG-UR-UCUG motif occur in similar structural contexts
in the authentic viral RNA. In each case, the motif is flanked
by base-paired regions: The first motif is flanked on the 5′ side
by the PAL1 intermolecular duplex and on the 3′ side by SL0. The
second motif is flanked on the 5′ side by the PAL2 duplex and on
the 3′ side by SL1 (Fig. 1A). To assess the contributions of these
structural elements for specific recognition by Gag, we evaluated
two recognition site (RS) RNAs. As a monomer, each RS RNA
spans one of the tandem UCUG motifs and its flanking double-
stranded regions (termed the PAL1-RS and PAL2-RS RNAs).
Gag binds to PAL1-RS and PAL2-RS with Kd’s of 120 and
110 nM, respectively (constructs 1–1 and 2–1, Fig. 5). This 20-fold
reduction in affinity, relative to the dimeric MiDAS construct
(Kapp;1 ∼ 6 nM), likely reflects that there are only one-fourth
as many Gag binding sites in each RS RNA; the simplified RNAs
may also be too short to support cooperative binding. The base-
paired regions that flank the tandem UCUG elements are critical
for high-affinity Gag interaction, as short single-stranded RNAs
containing only the UCUG-UR-UCUG motif bind Gag very
weakly (Kd > 1 μM, constructs 1–0 and 2–0, Fig. 5).
We evaluated the contributions of individual elements within
the PAL1-RS and PAL2-RS RNAs using an instructive set of
short RNAs derived from the two primary RS RNAs (Fig. 5 C
and D). PAL1-RS and PAL2-RS have slightly different sequences
in the 2-nt element that links the two UCUGmotifs (UG andUA,
respectively). The G residue in the 2-nt linker element does not
contribute to Gag recognition (constructs 1–2 and 2–2, Fig. 5 C
and D). Subsequent mutations in the PAL1-RS were tested in the
context of a UA linker sequence.
Mutating both G4 positions in the PAL1-RS RNA weakened
Gag binding by 3- to 5-fold (constructs 1–3 and 1–4, Fig. 5C), and
the equivalent change in PAL2-RS RNA reduced affinity 23-fold
(construct 2-3). Replacing the first G4 in PAL2-RS had a larger
effect than changing the second G4 (constructs 2-4a and 2-4b,
Fig. 5D). Mutating U1 in both UCUG sequences did not signifi-
cantly reduce binding to PAL1-RS (construct 1-5), but produced a
reproducible change of 3.5-fold in binding to PAL2-RS (construct
2-5). In each case, the effect of replacing both U1 and G4 was not
significantly different from that of replacing G4 alone (constructs
1-6 and 2-6, Fig. 5). Finally, we tested the role of the flanking
base-paired duplexes. In PAL1-RS, eliminating SL0 decreased
affinity ∼10-fold, whereas eliminating PAL1 had a smaller effect
(constructs 1-7 and 1-8); in PAL2-RS, removing either PAL2 or
SL1 reduced affinity ∼6-fold (constructs 2-7 and 2-8).
Effect of Mutation of UCUG Motifs upon Packaging of Viral RNA. The
in virio and in vitro biochemical studies described above strongly
suggest that a small number of interaction sites comprise key
binding structures for Gag and NC. We therefore evaluated the
role of the tandem UCUGmotifs in encapsidation of viral RNAs.
We generated mutations in these motifs in an MuLV-derived
luciferase vector whose first ∼1;040 nt are nearly identical to
MuLV (44) and compared the encapsidation efficiencies of the
mutant and native sequence RNAs. The G nucleotides were re-
placed with A in the 5′ UCUG repeats (M1), in the 3′ UCUG
repeats (M2), and in both tandem repeats (M1M2, see Fig. 1A).
These mutations were introduced with a C311U change, designed
to maintain native base pairing in the vRNA monomer. The
C311U mutation has no effect on packaging (Fig. 6). Each of
the mutant and wild-type vectors was transiently transfected into
293Tcells, together with an infectious MuLV plasmid clone. Cul-
ture fluids and cells were harvested and luciferase RNA levels in
the released particles and in the cells were quantified by real-time
RT-PCR. For each culture, the encapsidation efficiency was
calculated as the luciferase copies∕ng RNA in the viral sample
divided by the luciferase copies∕ng RNA in the cells (5).
Changing the UCUG motifs in the 5′ tandem repeat (mutant
M1) had a small, 4-fold, effect on encapsidation efficiency,
whereas mutation of the 3′ repeat reduced encapsidation effi-
ciency ∼12-fold (Fig. 6). However, changing all four UCUG
elements drastically reduced encapsidation of the vector: The
encapsidation efficiency of this mutant was ∼200-fold lower than
that of the native sequence control (M1M2, Fig. 6). These results
imply that G residues in the UCUGmotifs are crucial elements in
the MuLV packaging signal, but that there is some redundancy in
this signal: The presence of either the 5′ or the 3′ motif is suffi-
cient for partial encapsidation of vRNA.
Discussion
We have developed, and then applied, several unique experimen-
tal approaches to explore the signal that governs vRNA packa-
ging in the prototypical gammaretrovirus, MuLV. Specifically,
we analyzed the secondary structure of the vRNA within infec-
tious virions, probed the effects of NC upon this structure inside
the virion, and defined nucleotide-protein interactions in vitro
(Figs. 2 and 3). These experiments all pointed to the motif,
UCUG-UR-UCUG, as a specific binding site for Gag and NC
and indicated that NC is bound to this motif within the virion.
We then analyzed the binding of recombinant Gag to short
RNAs containing portions of the Ψ region. This binding is a spe-
cific interaction between MuLV Gag and the RNA, because it is
not seenwith the control basic peptide ðlysineÞ25, and is diminished
if individual G nucleotides in the motif are replaced by A residues
(Fig. 4). High-affinity binding ofGag to theRNA requires the pre-
sence of the 10-base tandem repeatmotif (which occurs twicewith-
in Ψ), which must also be flanked by base-paired regions (Fig. 5).
Prior work has shown that the MiDAS RNA dimer contains
true long-range tertiary interactions involving PAL1, PAL2,
and SL1-SL2 (38, 45). Thus, the simplest element in the packa-
ging signal involves both the primary sequence and the tertiary
architecture of the RNA. In particular, PAL2 likely packs against
the SL1-SL2 domain, which would cause the UCUG-UR-UCUG
motif to be presented to Gag as a loop (illustrated in Fig. 1B).
This model is also supported by a prior yeast three-hybrid study
that concluded that MuLV positions 212–354 are necessary for
high-affinity binding by Gag (32).
We then tested the functional role of this motif in the specific



























Fig. 4. Gag binding to the full-length MuLV dimerization domain. Data
points, shown as the mean and standard deviation for four replicates, were
fit to an equation for two independent binding events; R2 is ≥0.97 in all cases.
Kapp;1 for the native, M1, M2, and M1M2 RNAs are 6 2, 11 3, 12 3, and
35 12 nM, respectively.








elements within the two UCUG-UR-UCUGmotifs were changed
to UCUA, the efficiency with which genomic RNA was packaged
was reduced by ∼200-fold. A comparable effect is obtained by
deleting large regions of the packaging signal (150–350 nts) or
by introducing mutations that compromise dimerization (29, 46).
These results have important implications for the mechanism
of vRNA packaging and for RNA recognition, in general.
First, mutating only four bases in a retroviral RNA leads to
a drastic effect on encapsidation in a dimerization-competent
RNA (Fig. 6). The large size of the region identified previously
as necessary for packaging reflects both the requirement to main-
tain a specific three-dimensional architecture and to present sin-
gle-stranded elements for recognition by Gag. Similar principles
also appear to govern selective packaging of HIV-1 vRNA: The
strongest SHAPE-detected effects of HIV-1 NC protein binding
to the viral RNA occur at single-stranded elements flanked on
both sides by base-paired elements (39).
Second, our results show that, in MuLV, the binding specificity
of Gag for RNA differs from that of NC in at least two critical
ways. Whereas a near-stoichiometric number of Gag molecules is
sufficient to bind the UCUG-UR-UCUG motif, a large excess of
NC is required to induce a similar change in RNA structure as
measured by SHAPE (Fig. S1). In addition, NC and Gag binding
induce distinct changes in RNA structure, especially at positions
220–223 and 299–309 (Fig. 3). Overall, Gag binds much more
selectively to the dimeric RNA than does NC, probably due to
molecular cooperativity, the presence of MA, or both.
Third, this work rationalizes how recognition of a simple 4-nt
sequence element (26, 28), with a low information content, could
mediate specific packaging of an entire viral RNA genome. It was
proposed many years ago that dimeric RNAs are selectively pack-
aged (15, 47, 48), and an important initial proposal emphasized
that dimerization of MuLV vRNA constitutes a switch that
exposes UCUG sequences (25, 26, 33). In fact, Gag actually binds
weakly (Kd ≥ 1 μM) to short single-stranded RNAs containing
only this motif (Fig. 5, constructs 1-0 and 2-0). Thus, the full
RNA recognition code is an information-rich structure involving
tandemly repeated motifs positioned between flanking base-
paired elements (Fig. 1B).
Diverse cellular regulation processes are mediated by RNA
binding proteins that, like NC, recognize short, often degenerate,
sequence elements (49). This work illustrates how the full recog-
nition code for this class of proteins is linked to the underlying
RNA structure and also outlines broadly applicable functional
tools for dissecting this code.
Methods
In Virio Probing of MuLV Genome Dimer Structure by SHAPE. Moloney MuLV
particles were resuspended in HFS buffer [2 mL; 50 mM Hepes (pH 8.0),
200 mM NaCl, 0.1 mM EDTA, 10% (vol∕vol) fetal bovine serum], divided into
two equal aliquots, and treated with either Aldrithiol-2 (AT-2, 2,2′-dithioldi-
pyridine) in DMSO (2 μL of 0.5 mM stock) or DMSO alone and incubated over-
night at 4 °C. Virions were then purified over a sucrose cushion, resuspended
in 1 mL HFS buffer, divided into two aliquots, and treated either with
N-methyl isatoic anhydride (NMIA, 50 μL of 100 mM in DMSO) or neat DMSO.
In Vitro SHAPE Analysis of MiDAS Dimers in the Presence of Gag and NC. MuLV
dimers were formed from a 331-nt RNA (33). Purified recombinant MuLV Gag
and NCwere incubated with MuLV dimers (18 μL, in 40 mMNaCl or potassium
acetate for Gag and NC, respectively, and 0.8 mM MgCl2) and were treated
with 1-methyl-7-nitroisatoic anhydride (1M7, 2 μL; 2 mM in anhydrous DMSO)
or with neat DMSO.
A B
DC
Fig. 5. Defining the minimal RNA binding motif for Gag.
(A and B) Representative analysis of Gag binding to the
PAL1-RS and PAL2-RS RNAs. Kd ’s for PAL1-RS and PAL2-RS
(constructs 1-1 and 2-1) are 120 and 110 nm, respectively.
(C and D) Effect of point mutations on Gag binding to
PAL1-RS and PAL2-RS. Mutated sites relative to the native
sequence are shown in red. Binding affinities for the mu-





larger values indicate weaker binding. Krel values larger
than 2 are emphasized in red.
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Detection of NMIA and 1M7 Modifications. Sites of 2′-O-adduct formation in
the authentic MuLV genome or in simplified transcript RNAs were analyzed
by capillary electrophoresis using fluorescently labeled DNA primers and
reverse transcriptase-mediated primer extension (33).
Gag Binding Affinities and Dimerization Controls for MiDAS RNA Constructs.
Equilibrium dissociation constants were measured using a dual filter system
in 50 mM Hepes (pH 7.6), 40 mM potassium acetate (pH 7.7), 0.8 mM MgCl2,
0.2 mM DTT, 100 μg∕mL BSA, and 0.01% (vol∕vol) Triton X-100 and contain-
ing excess yeast tRNAPhe and trace (0.10 nM) [32P]-labeled RNA. Binding data
for the intact dimerization domain were fit assuming two independent
sites; for the PAL(1 or 2)-RS constructs, data were fit to single-site equation.
Viral Packaging Experiments. Encapsidation efficiencies for native sequence
and Ψ region mutants were measured using pBabe-Luc (44), a derivative
of a MuLV-based vector.
Additional details regarding the methods for vRNA isolation, SHAPE
analysis and data processing, Gag binding experiments, and virus packaging
are available in the SI Text.
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Fig. 6. Normalized encapsidation efficiencies for MuLV-derived pBabe-Luc
RNAs containing native sequence and mutant Ψ domains. Geometric means
and standard deviations are shown.
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